136 related articles for article (PubMed ID: 34709805)
21. Metabolic engineering of indole pyruvic acid biosynthesis in Escherichia coli with tdiD.
Zhu Y; Hua Y; Zhang B; Sun L; Li W; Kong X; Hong J
Microb Cell Fact; 2017 Jan; 16(1):2. PubMed ID: 28049530
[TBL] [Abstract][Full Text] [Related]
22. Metabolic engineering of the moss Physcomitrella patens to produce the sesquiterpenoids patchoulol and α/β-santalene.
Zhan X; Zhang YH; Chen DF; Simonsen HT
Front Plant Sci; 2014; 5():636. PubMed ID: 25477891
[TBL] [Abstract][Full Text] [Related]
23. Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A.
Zhou L; Ding Q; Jiang GZ; Liu ZN; Wang HY; Zhao GR
Microb Cell Fact; 2017 May; 16(1):84. PubMed ID: 28511681
[TBL] [Abstract][Full Text] [Related]
24. Advances in biotechnological production of santalenes and santalols.
Zha WL; Zi JC
Chin Herb Med; 2021 Jan; 13(1):90-97. PubMed ID: 36117763
[TBL] [Abstract][Full Text] [Related]
25. The santalene synthase from Cinnamomum camphora: Reconstruction of a sesquiterpene synthase from a monoterpene synthase.
Di Girolamo A; Durairaj J; van Houwelingen A; Verstappen F; Bosch D; Cankar K; Bouwmeester H; de Ridder D; van Dijk ADJ; Beekwilder J
Arch Biochem Biophys; 2020 Nov; 695():108647. PubMed ID: 33121934
[TBL] [Abstract][Full Text] [Related]
26. Revisiting sesquiterpene biosynthetic pathways leading to santalene and its analogues: a comprehensive mechanistic study.
Jindal G; Sunoj RB
Org Biomol Chem; 2012 Oct; 10(39):7996-8006. PubMed ID: 22951817
[TBL] [Abstract][Full Text] [Related]
27. Regulatory molecule cAMP changes cell fitness of the engineered Escherichia coli for terpenoids production.
Jeong SH; Park JB; Wang Y; Kim GH; Zhang G; Wei G; Wang C; Kim SW
Metab Eng; 2021 May; 65():178-184. PubMed ID: 33246165
[TBL] [Abstract][Full Text] [Related]
28. Improvement of isoprene production in Escherichia coli by rational optimization of RBSs and key enzymes screening.
Li M; Chen H; Liu C; Guo J; Xu X; Zhang H; Nian R; Xian M
Microb Cell Fact; 2019 Jan; 18(1):4. PubMed ID: 30626394
[TBL] [Abstract][Full Text] [Related]
29. Toward industrial production of isoprenoids in Escherichia coli: Lessons learned from CRISPR-Cas9 based optimization of a chromosomally integrated mevalonate pathway.
Alonso-Gutierrez J; Koma D; Hu Q; Yang Y; Chan LJG; Petzold CJ; Adams PD; Vickers CE; Nielsen LK; Keasling JD; Lee TS
Biotechnol Bioeng; 2018 Apr; 115(4):1000-1013. PubMed ID: 29278415
[TBL] [Abstract][Full Text] [Related]
30. Metabolic engineering of glycolysis in Escherichia coli for efficient production of patchoulol and τ-cadinol.
Zhou L; Wang Q; Shen J; Li Y; Zhang H; Zhang X; Yang S; Jiang Z; Wang M; Li J; Wang Y; Liu H; Zhou Z
Bioresour Technol; 2024 Jan; 391(Pt B):130004. PubMed ID: 37952591
[TBL] [Abstract][Full Text] [Related]
31. Systems metabolic engineering of Bacillus subtilis for efficient biosynthesis of 5-methyltetrahydrofolate.
Yang H; Liu Y; Li J; Liu L; Du G; Chen J
Biotechnol Bioeng; 2020 Jul; 117(7):2116-2130. PubMed ID: 32170863
[TBL] [Abstract][Full Text] [Related]
32. Engineering Escherichia coli for the synthesis of short- and medium-chain α,β-unsaturated carboxylic acids.
Kim S; Cheong S; Gonzalez R
Metab Eng; 2016 Jul; 36():90-98. PubMed ID: 26996381
[TBL] [Abstract][Full Text] [Related]
33. Manipulation of the precursor supply for high-level production of longifolene by metabolically engineered Escherichia coli.
Cao Y; Zhang R; Liu W; Zhao G; Niu W; Guo J; Xian M; Liu H
Sci Rep; 2019 Jan; 9(1):95. PubMed ID: 30643175
[TBL] [Abstract][Full Text] [Related]
34. Improved Production and In Situ Recovery of Sesquiterpene (+)-Zizaene from Metabolically-Engineered
Aguilar F; Scheper T; Beutel S
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540161
[TBL] [Abstract][Full Text] [Related]
35. Improved production of 1-deoxynojirymicin in Escherichia coli through metabolic engineering.
Rayamajhi V; Dhakal D; Chaudhary AK; Sohng JK
World J Microbiol Biotechnol; 2018 May; 34(6):77. PubMed ID: 29796897
[TBL] [Abstract][Full Text] [Related]
36. Increasing L-homoserine production in Escherichia coli by engineering the central metabolic pathways.
Liu M; Lou J; Gu J; Lyu XM; Wang FQ; Wei DZ
J Biotechnol; 2020 May; 314-315():1-7. PubMed ID: 32251699
[TBL] [Abstract][Full Text] [Related]
37. Metabolic engineering of Escherichia coli for production of valerenadiene.
Nybo SE; Saunders J; McCormick SP
J Biotechnol; 2017 Nov; 262():60-66. PubMed ID: 28988031
[TBL] [Abstract][Full Text] [Related]
38. Modular pathway engineering for resveratrol and piceatannol production in engineered Escherichia coli.
Shrestha A; Pandey RP; Pokhrel AR; Dhakal D; Chu LL; Sohng JK
Appl Microbiol Biotechnol; 2018 Nov; 102(22):9691-9706. PubMed ID: 30178203
[TBL] [Abstract][Full Text] [Related]
39. Constructing a synthetic constitutive metabolic pathway in Escherichia coli for (R, R)-2,3-butanediol production.
Tong YJ; Ji XJ; Shen MQ; Liu LG; Nie ZK; Huang H
Appl Microbiol Biotechnol; 2016 Jan; 100(2):637-47. PubMed ID: 26428232
[TBL] [Abstract][Full Text] [Related]
40. [Improving β-carotene production in Escherichia coli by metabolic engineering of glycerol utilization pathway].
Dong Y; Hu K; Li X; Li Q; Zhang X
Sheng Wu Gong Cheng Xue Bao; 2017 Feb; 33(2):247-260. PubMed ID: 28956381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
